Apyx Medical (APYX) Income from Continuing Operations (2011 - 2026)
Apyx Medical's (APYX) quarterly Income from Continuing Operations came in at 2143000.0 in Q1 2026, up 48.63% YoY from 1441799.06 in Q1 2025, and up 49.69% on a QoQ basis from 4260000.0 in Q4 2025.
Apyx Medical (APYX) Income from Continuing Operations (2011 - 2026) Analysis & Trends
Apyx Medical (APYX) has 16 years of Income from Continuing Operations data on file, last reported at 2143000.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 48.63% year-over-year to 2143000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 12096000.0 (up 45.91% YoY) and the FY2025 annual result came in at 14125000.0, up 45.21% from the prior year.
- Income from Continuing Operations advanced to 2143000.0 in Q1 2026, from 4260000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 1019000.0 in Q2 2023 to a low of 9624000.0 in Q4 2023.
- A 5-year average of 4951588.24 and a median of 4724000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations jumped 81.3% — and 2024, when it sank 546.32%.
- Tracing APYX's Income from Continuing Operations over 5 years: stood at 6065000.0 in 2022, then sank by 58.68% to 9624000.0 in 2023, then advanced by 28.5% to 6881000.0 in 2024, then jumped by 38.09% to 4260000.0 in 2025, then soared by 49.69% to 2143000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 2143000.0 (Q1 2026), 4260000.0 (Q4 2025), and 1955000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Apyx Medical | 136.81 Mn | 109.19 Mn | 8.87 Mn | -3.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.07 Mn |
| Mar 31, 2026 | -2.14 Mn |
| Dec 31, 2025 | -4.26 Mn |
| Sep 30, 2025 | -1.96 Mn |
| Jun 30, 2025 | -3.74 Mn |
| Mar 31, 2025 | -4.17 Mn |
| Dec 31, 2024 | -6.88 Mn |
| Sep 30, 2024 | -4.72 Mn |
| Jun 30, 2024 | -6.59 Mn |
| Mar 31, 2024 | -7.59 Mn |
| Dec 31, 2023 | -9.62 Mn |
| Sep 30, 2023 | -4.68 Mn |
| Jun 30, 2023 | -1.02 Mn |
| Mar 31, 2023 | -3.53 Mn |
| Dec 31, 2022 | -6.07 Mn |
| Sep 30, 2022 | -5.80 Mn |
| Jun 30, 2022 | -5.45 Mn |
| Mar 31, 2022 | -5.97 Mn |
| Dec 31, 2021 | -2.01 Mn |
| Sep 30, 2021 | -4.23 Mn |